Overview

Escitalopram (Lexapro) for Depression MS or ALS

Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if escitalopram (Lexapro) improves symptoms of major depressive disorder in patients who have ALS or MS.
Phase:
Phase 3
Details
Lead Sponsor:
University of South Carolina
Treatments:
Citalopram
Dexetimide